Evidence map›Paper›PMID 27624485›Full record

Trial reportBMC cardiovascular disorders2016

Oral anticoagulation with vitamin K inhibitors and determinants of successful self-management in primary care.

E Tamayo Aguirre, A Galo-Anza, O Dorronsoro-Barandiaran, E Uranga-Saez Del Burgo, A Ostiza Irigoyen, A Garcia-Carro, I Lopez-Fernandez, N Colera, P Saez-Garbayo, I Tamayo-Uria

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01878539 (Oral Anticoagulation and Self-management), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01878539 naunknown statusnot on this map

Oral Anticoagulation and Self-management: Analysis of the Factors That Determine the Feasibility of Using Self-testing and Self-management in Primary Care

TypeinterventionalSponsorOsakidetzaRan2012 to 2014Enrolled333ConditionsAtrial Fibrillation, EmbolismArmscoagulometer, training programme
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Point of care INR monitoring in cyanotic congenital heart disease-related compensatory erythrocytosis.International journal of cardiology. Congenital heart disease · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

E Tamayo AguirreGros Health Centre, Donostia, Gipuzkoa, Spain. tamayoedua@gmail.com.
A Galo-AnzaGros Health Centre, Donostia, Gipuzkoa, Spain.
O Dorronsoro-BarandiaranGros Health Centre, Donostia, Gipuzkoa, Spain.
E Uranga-Saez Del BurgoPasai Donibane Health Centre, Gipuzkoa, Spain.
A Ostiza IrigoyenUsurbil Health Centre, Gipuzkoa, Spain.
A Garcia-CarroEgia Health Centre, Donostia, Spain.
I Lopez-FernandezLasarte Health Centre, Gipuzkoa, Spain.
N ColeraLezo Health Centre, Gipuzkoa, Spain.
P Saez-GarbayoAmara Health Centre, Gipuzkoa, Spain.
I Tamayo-UriaISGlobal Barcelona Institute for Global Health, Barcelona, Spain.
Policlínica Gipuzkoa · ESBiogipuzkoa Health Research Institute · ESDiputación Foral de Gipuzkoa · ESPompeu Fabra University · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSelf-management may be an option to monitor oral anticoagulant therapy in health systems, but before recommending it, we need to assess patients' ability to take on this task. The purpose of the study was to describe patients' ability to self-manage and associated factors.

methodsThis was a 3-year prospective quasi-experimental study with a control group. Overall, 333 patients on anticoagulant therapy from seven primary care health centres of the Basque Health Service were included in the intervention group and followed up for 6 months after the intervention, assessing their ability to self-test and self-manage. The intervention consisted of a patient training programme, providing detailed information on their condition and its treatment, and practical training in how to use a portable blood coagulation monitor and adjust their anticoagulant dose. Comparisons were made with a control group (333 patients receiving OAT under usual care from the same seven health centres). Outcome variables were ability to self-manage, quality of the outcome (in terms of time in therapeutic range), and quality of life in the intervention group, and general patient characteristics (age and sex), clinical variables (reason for OAT, INR range), and quality of the outcome (in terms of percentage of INR measurements in range and complications) in both groups.

resultsOverall, 26.13 % of patients invited to participate in the intervention agreed. Of these, 99 % successfully learned to self-manage their OAT. Just 4.2 % did not complete the follow-up, in all cases for reasons unrelated to self-management, and 4.5 % required additional learning support. Outcomes were better than under usual care in terms of percentage of INR measurements in range (12 %), rate of complications (4 %) and quality of life (9.2 %). LIMITATIONS: Patients were only followed-up period for 6 months and the study was conducted in a single health organization. Though patients eligible to participate were selected randomly, they were not randomly allocated to the groups. This is a potential source of selection bias. Data needed to calculate in-range time were not collected from controls; rather the results for the self-management group were compared with external data from other studies.

conclusionsAlmost all participants achieved competency in self-management, with no differences by age, sex, concurrent illnesses, polypharmacy or educational level. The greatest barrier to self-management was the attitude of patients themselves and those around them. Self-management in primary care is a good alternative to usual care, patients having longer times in therapeutic range and fewer complications, and improving their quality of life. Remote management is a good support tool.

trial registrationClinicalTrials.gov Identifier: NCT01878539.

Indexed as

Quality of LifeAdministration, OralAgedAnticoagulantsBlood CoagulationDose-Response Relationship, DrugFemaleFollow-Up StudiesHumansMalePatient SatisfactionPrimary Health CareProspective StudiesSelf CareThromboembolismTime FactorsAnticoagulantsVitamin KAbilitiesAccessOATQuality of lifeSelf-managementTime in therapeutic range

Identifiers

PMID27624485
PMCPMC5022157
OpenAlexW2520018962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.